Send feedback

DDOST p.Ala259Val

c.776C>T · rs138061134 · VCV295135

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
AlphaMissense
likely benign
0.1832 · ACMG-weighted
gnomAD v4.1
Rare
low-frequency (popmax 1.15%, eas)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
DDOST-congenital disorder of glycosylation

Computational evidence

Protein change
AlphaMissense0.1832likely benign
REVEL0.399indeterminate
SaProtLLR -7.95tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAIΔ0.53donor gain · deltas
PangolinΔ0.28gain · loss 0.05 · agrees with SpliceAI · independent
Constraint at this position
ConservationphyloP 9.7GERP 1.3, phastCons 1
Regional constrainto/e 0.92unconstrained · MANE · 8,968 bp · p 0.046 · regional, not allelic
Overall
CADD26.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM A276V vs ClinVar A259V) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 1.15% East Asian · 471/40,946 alleles
Filtering AF 1.06% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.03%
Overall 0.158% 2,454/1,550,972 alleles · low-frequency
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 1.34% 75
East Asiangrpmax 1.15% 87
Remaining individualsnot grpmax-eligible 0.142% 706
Middle Eastern 0.131% 761
South Asian 0.123% 816
European (non-Finnish) 0.0836% 1,196
Ashkenazi Jewishnot grpmax-eligible 0.0733% 1,364
Admixed American 0.0098% 10,202
African / African-American 0.00273% 36,572

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DDOST
Protein
p.Ala259Val
Coding
c.776C>T
MANE Select
NM_005216
dbSNP
rs138061134
Type
single nucleotide variant
Location
chr1:20654241 (GRCh38)
Gene constraint
LOEUF 0.747 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 89.27 · 6 PDB
Residue 259
a β-strand
Full DDOST gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

DDOST-congenital disorder of glycosylation — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For DDOST-CDG (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ddost-p-ala259val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown